To buy shares in OKYO Pharma Limited you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $1.66 to buy one share in OKYO Pharma Limited (as of 10:00 04-Jun-2026). Which is a change of $0.08 or 4.82% from the last closing price of $1.66.
How To Buy OKYO Pharma Limited Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in OKYO Pharma Limited:
- Pick a stock broker (jump down to compare the best brokers for buying OKYO Pharma Limited stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:OKYO)
- Choose the number of shares you want to buy (1 share currently costs $1.66)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your OKYO Pharma Limited stock in your account (this will show your profit and loss)
- OKYO Pharma Limited is currently worth $91,313,895 based on the last closing price of $1.66 with 11,291 shares traded.
- The most recent OKYO Pharma Limited daily high has been $1.75 and daily low $1.65.
- The OKYO Pharma Limited stock price 52 week high has been $3.35 and the 52 week low $1.44.
Compare Brokers For Buying OKYO Pharma Limited Stock
Is Now A Good Time To Buy OKYO Pharma Limited Stock?
- OKYO Pharma Limited’s EPS (earnings per share) are 0.15. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- OKYO Pharma Limited’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below OKYO Pharma Limited share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.